Why soy is so good!
February 13, 2003
A recent Japanese study found soy has the potential to reduce the risks of postmenopausal osteoporosis and cardiovascular disease in women.
Postmenopausal osteoporosis is associated with oestrogen deficiency. Oestrogens are known to have effects not only on bone metabolism, but also on cholesterol metabolism and blood pressure. Oestrogen replacement therapy is often considered for reducing bone loss and other symptoms in women who have been through menopause.
However such therapy may have serious side-effects. Another option to be considered is the use of weak oestrogen-like compounds. Isoflavones, have an oestrogenic effect and are known as phytoestrogens or plant oestrogens. Soybean has a high isoflavone content and is widely consumed in many Asian countries.
This study examined the possibility that supplemental isoflavone intake would both decrease bone turnover and alter blood lipids in postmenopausal Japanese women who already have high daily dietary intakes of soybean products. Thus, the isoflavone intake during the study was in addition to the common dietary intake among Japanese.
23 healthy Japanese women age 40 - 62 years took part in the study and were randomly assigned to either isoflavone or placebo. 12 women received daily capsules of soy isoflavone extract (61.8mg of isoflavones) and 11 women received placebo capsules for 4 weeks.
The 23 subjects documented their food intake for the trial period. Based on these records, daily isoflavone intakes were calculated for each subject. The results of this study found :
Total and LDL cholesterol decreased significantly in the isoflavone group
Excretion of bone resorption markers was reduced significantly in the isoflavone group thus indicating a reduction in the rate of bone loss
Isoflavone supplementation did not affect liver function
No side effects were detected
The researchers conclude that, "our data confirms isoflavones had beneficial effects on bone and lipid metabolisms, suggesting they may be useful for preventing both osteoporosis and coronary heart diseases."
REFERENCES
Uesugi T et al. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study. J Am coll Nutr. 2002;21(2):97-102
Other links
http://www.ironmagazineforums.com/showthread.php?s=&threadid=16776
http://www.ironmagazineforums.com/showthread.php?s=&threadid=16689
http://www.ironmagazineforums.com/showthread.php?s=&threadid=16800
February 13, 2003
A recent Japanese study found soy has the potential to reduce the risks of postmenopausal osteoporosis and cardiovascular disease in women.
Postmenopausal osteoporosis is associated with oestrogen deficiency. Oestrogens are known to have effects not only on bone metabolism, but also on cholesterol metabolism and blood pressure. Oestrogen replacement therapy is often considered for reducing bone loss and other symptoms in women who have been through menopause.
However such therapy may have serious side-effects. Another option to be considered is the use of weak oestrogen-like compounds. Isoflavones, have an oestrogenic effect and are known as phytoestrogens or plant oestrogens. Soybean has a high isoflavone content and is widely consumed in many Asian countries.
This study examined the possibility that supplemental isoflavone intake would both decrease bone turnover and alter blood lipids in postmenopausal Japanese women who already have high daily dietary intakes of soybean products. Thus, the isoflavone intake during the study was in addition to the common dietary intake among Japanese.
23 healthy Japanese women age 40 - 62 years took part in the study and were randomly assigned to either isoflavone or placebo. 12 women received daily capsules of soy isoflavone extract (61.8mg of isoflavones) and 11 women received placebo capsules for 4 weeks.
The 23 subjects documented their food intake for the trial period. Based on these records, daily isoflavone intakes were calculated for each subject. The results of this study found :
Total and LDL cholesterol decreased significantly in the isoflavone group
Excretion of bone resorption markers was reduced significantly in the isoflavone group thus indicating a reduction in the rate of bone loss
Isoflavone supplementation did not affect liver function
No side effects were detected
The researchers conclude that, "our data confirms isoflavones had beneficial effects on bone and lipid metabolisms, suggesting they may be useful for preventing both osteoporosis and coronary heart diseases."
REFERENCES
Uesugi T et al. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study. J Am coll Nutr. 2002;21(2):97-102
Other links
http://www.ironmagazineforums.com/showthread.php?s=&threadid=16776
http://www.ironmagazineforums.com/showthread.php?s=&threadid=16689
http://www.ironmagazineforums.com/showthread.php?s=&threadid=16800
